Transparency in Health Economic Modeling: Options, Issues and Potential Solutions

被引:0
|
作者
Eric Q. Wu
Zheng-Yi Zhou
Jipan Xie
Cinzia Metallo
Praveen Thokala
机构
[1] Analysis Group,
[2] Analysis Group,undefined
[3] Analysis Group,undefined
[4] University of Sheffield,undefined
来源
PharmacoEconomics | 2019年 / 37卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Economic models are increasingly being used by health economists to assess the value of health technologies and inform healthcare decision making. However, most published economic models represent a kind of black box, with known inputs and outputs but undisclosed internal calculations and assumptions. This lack of transparency makes the evaluation of the model results challenging, complicates comparisons between models, and limits the reproducibility of the models. Here, we aim to provide an overview of the possible steps that could be undertaken to make economic models more transparent and encourage model developers to share more detailed calculations and assumptions with their peers. Scenarios with different levels of transparency (i.e., how much information is disclosed) and reach of transparency (i.e., who has access to the disclosed information) are discussed, and five key concerns (copyrights, model misuse, confidential data, software, and time/resources) pertaining to model transparency are presented, along with possible solutions. While a shift toward open-source models is underway in health economics, as has happened before in other research fields, the challenges ahead should not be underestimated. Importantly, there is a pressing need to find an acceptable trade-off between the added value of model transparency and the time and resources needed to achieve such transparency. To this end, it will be crucial to set incentives at different stakeholder levels. Despite the many challenges, the many benefits of publicly sharing economic models make increased transparency a goal worth pursuing.
引用
收藏
页码:1349 / 1354
页数:5
相关论文
共 50 条
  • [1] Transparency in Health Economic Modeling: Options, Issues and Potential Solutions
    Wu, Eric Q.
    Zhou, Zheng-Yi
    Xie, Jipan
    Metallo, Cinzia
    Thokala, Praveen
    [J]. PHARMACOECONOMICS, 2019, 37 (11) : 1349 - 1354
  • [2] Improving Transparency in Decision Models: Current Issues and Potential Solutions
    Tappenden, Paul
    Caro, J. Jaime
    [J]. PHARMACOECONOMICS, 2019, 37 (11) : 1303 - 1304
  • [3] Improving Transparency in Decision Models: Current Issues and Potential Solutions
    Paul Tappenden
    J. Jaime Caro
    [J]. PharmacoEconomics, 2019, 37 : 1303 - 1304
  • [4] CHALLENGES IN HEALTH ECONOMIC EVALUATION OF GENE REPLACEMENT THERAPIES: POTENTIAL SOLUTIONS FOR KEY METHODOLOGICAL ISSUES
    Thokagevistk, K.
    Aballea, S.
    Millier, A.
    Francois, C.
    Toumi, M.
    [J]. VALUE IN HEALTH, 2019, 22 : S419 - S419
  • [5] The Potential for REDD plus : Key Economic Modeling Insights and Issues
    Lubowski, Ruben N.
    Rose, Steven K.
    [J]. REVIEW OF ENVIRONMENTAL ECONOMICS AND POLICY, 2013, 7 (01) : 67 - 90
  • [6] Corporate Transparency: Economic Feasibility and Regulatory Issues
    Ruzhanskaya, Ludmila
    [J]. EKONOMICHESKAYA POLITIKA, 2010, (05): : 156 - +
  • [7] Transparency of Economic Evaluations of Health Technologies
    Joan Rovira
    [J]. PharmacoEconomics, 2008, 26 : 181 - 183
  • [8] Transparency of economic evaluations of health technologies
    Rovira, Joan
    [J]. PHARMACOECONOMICS, 2008, 26 (03) : 181 - 183
  • [9] Education needs and health insurance options: Critical gaps and potential solutions for Texas
    Atnip, S
    Buitrago, K
    Lindberg, K
    Starr, D
    [J]. INVESTING IN TEXAS: FINANCING HEALTH COVERAGE EXPANSION, CONFERENCE BACKGROUND PAPERS, 2003, : 231 - 318
  • [10] Development and Use of Disease-Specific (Reference) Models for Economic Evaluations of Health Technologies: An Overview of Key Issues and Potential Solutions
    Frederix, Gerardus W. J.
    Afzali, Hossein Haji Ali
    Dasbach, Erik J.
    Ward, Robyn L.
    [J]. PHARMACOECONOMICS, 2015, 33 (08) : 777 - 781